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Abstract: Mitochondria are major determinants of cell fate in ischemia/reperfusion injury (IR) and
common effectors of cardio-protective strategies in cardiac ischemic disease. Thyroid hormone
homeostasis critically affects mitochondrial function and energy production. Since a low T3 state
(LT3S) is frequently observed in the post infarction setting, the study was aimed to investigate the
relationship between 72 h post IR T3 levels and both the cardiac function and the mitochondrial
proteome in a rat model of IR. The low T3 group exhibits the most compromised cardiac
performance along with the worst mitochondrial activity. Accordingly, our results show a different
remodeling of the mitochondrial proteome in the presence or absence of a LT3S, with alterations in
groups of proteins that play a key role in energy metabolism, quality control and regulation of cell
death pathways. Overall, our findings highlight a relationship between LT3S in the early post IR and
poor cardiac and mitochondrial outcomes, and suggest a potential implication of thyroid hormone
in the cardio-protection and tissue remodeling in ischemic disease.
Keywords: low T3 state; ischemia/reperfusion; mitochondrial function; mitochondria
proteomic profiling
1. Introduction
Acute myocardial infarction (AMI) leading to ischemic heart disease is a major cause of death
worldwide. Although timely reperfusion effectively reduces short-term mortality, restoration of
blood flow also leads to ischemia/reperfusion (IR) injury which in the long run prompts adverse
cardiac remodeling. Thus, limiting cardiac damage in the early stages of the wound healing process
is a critical step to improve patient prognosis.
Mitochondrial dysfunction is a key pathogenic event in cardiac IR and disease progression [1–3].
As a consequence, preserving mitochondrial function is essential to limit myocardial damage in
ischemic heart disease. The main mechanisms for post IR mitochondrial dysfunction include
impairment in electron transport chain (ETC) complex activities [4,5], defects in supermolecular
assembly of ETC complexes [6–8], impaired ionic homeostasis and formation of reactive oxygen
species (ROS) [9], and impaired tricarboxylic acid (TCA) cycle anaplerosis, [10,11]. In light of
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this complex scenario, protein profiling has emerged as a powerful tool allowing for simultaneous
measurement of the levels of many mitochondrial proteins in a single analysis [12–14]. Moreover,
analyses of the mitochondrial proteome prove useful not only to expand our knowledge of
mitochondrial function in physio/pathological states, but also to unveil potential strategies for
therapeutic intervention [15].
Triiodothyronine (T3), the biologically active thyroid hormone (TH), is considered a major
regulator of mitochondrial activity [16–18]. The breakdown of thyroid system homeostasis is
associated with bioenergetic remodelling of cardiac mitochondria which leads to severe alterations
in the biochemistry, structure and contractility of cardiac muscle [17]. Clinical evidence shows
post IR declines of T3, known as low T3 state (LT3S) [19–21] that represent a strong independent
prognostic predictor of death and major adverse cardiac events [22]. Accordingly LT3S correction
exerts cardioprotective actions both in the clinical arena and in animal models of post ischemic cardiac
diseases [23–25]. Since mitochondria are critical effectors of the T3 cardioprotective signaling [26,27],
characterization of the mitochondrial proteome remodeling in the post IR-LT3S model may reveal
candidate proteins and pathways related to this signaling.
The main objective of the present study is to compare the post IR rat mitochondrial proteome in
the early phase of wound healing between normal and low T3 states. Differentially expressed proteins
were assessed in comparison to sham operated animals. Our data indicate that mitochondrial
proteomic alteration and dysfunction are mainly associated with a post IR decrease of T3 levels.
2. Results
2.1. Validation of the Post IR Low-T3 State (LT3S) Model
We have previously observed that in our AMI model, cardiac TH concentrations closely reflect
those of the circulating free TH [27,28]. Therefore, in the present study the circulating levels of
free T3 (FT3) and free T4 (FT4) were assessed at baseline and 3 days (3d) post-surgery to track
the myocardial TH status. As summarized in Table 1, sham operation did not significantly change
serum TH concentrations. No significant alterations of 3d FT3 or FT4 were measured even in IR-NT3
group, while a significant reduction of FT3 concentration was observed three days post-surgery in
IR-LT3S rats. This difference should not be attributed to different degree of LV damage since all
ischemia-injured rats exhibited the same damage score as well as comparable percentage of area at
risk (AAR) (Table 1). These findings confirmed the previous observation about the occurrence of
a L-T3S in a subset of animals in the early post-ischemic setting [27]. In accordance with clinical
data, the L-T3S condition was observed in about 30% of ischemia-reperfused rats with matching
degrees of damaged myocardium, thus suggesting that the Low-T3S rat may represent a useful
preclinical model.
2.2. Post IR Myocardial Functional Parameters and Mitochondrial Activity
As a second step, we asked if the observed FT3 decrease in the L-T3S group could be associated
with an impaired recovery of post-ischemic cardiac function and chamber geometry. Although both
groups of infarcted rats showed similar alterations of the LV fractional shortening (FS), and the end
systolic LV diameter (Figure 1A), only the IR-LT3 group exhibited a significant reduction of the
systolic anterior wall thickening (SAWT) with respect to both sham and IR-NT3 group (Figure 1A)
suggesting that a post IR L-T3S is associated with a significant reduction in regional contractility of
LV within the AAR. To strengthen the hypothesis of a relationship between the variation of T3 levels
(three days after IR with respect to the basal level) and the cardiac functional parameter SAWT, a
non linear regression (sigmoid model) was applied to derive the EC50, i.e., the delta T3 concentration
that provokes a response half way between the minimal response (bottom point) and the maximal
response (top point) (Figure 1B). The derived EC50 was equal to ´0.39, a value that falls between
LT3S and NT3 groups, and may be considered a clear cutoff of the delta T3 level.
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Table 1. Serum free thyroid hormone and LV damage index.
TH Level
(pg/mL)
Sham IR-NT3 IR-LT3S
Mean˘ SEM Median (IQR) Mean˘ SEM Median (IQR) Mean˘ SEM Median (IQR)
FT3 basal 3.2˘ 0.3 3.6 (2.7–3.8) 3.2˘ 0.3 3.2 (2.6–3.9) 3.5˘ 0.3 3.4 (3.3–3.6)
FT3 final 3.5˘ 0.2 3.8 (3.1–3.8) 3.3˘ 0.3 3.6 (2.6–3.6) 2.2˘ 0.3 *,#,: 2.3 (1.9–2.4) §,&,+
FT4 basal 12.4˘ 0.6 13.4 (11.6–13.7) 13.0˘ 0.7 13.3 (12.9–13.7) 12.1˘ 1.0 13.7 (13.5–14.3)
FT4 final 12.1˘ 1.5 12.6 (10.9–13.8) 14.3˘ 1.8 14.3 (12.7–16.3) 13.3˘ 1.6 10.4 (10.1–10.8)
Damage
Index
Sham IR-NT3 IR-LT3S
– Mean˘ SEM Mean˘ SEM
Arrhythmic
severity
score
NA 3.3˘ 0.4 3.4˘ 0.3
Area at risk
(% of LV) NA 48˘ 3 47˘ 5
Free T3 (FT3) and free T4 (FT4) were measured before and 72 h post-IR; n = 5. Left columns report
mean values ˘ SEM: * p = 0.006 vs. respective basal levels; # p = 0.004 vs. sham-operated; : p = 0.009 vs.
IR-NT3. Right columns report median values and interquartile range (IQR), along with the corresponding non
parametric analysis: § p = 0.04 vs. respective basal levels; & p = 0.009 vs. sham-operated; + p = 0.014 vs. IR-NT3.
Arrhythmic score was calculated based on ECG data obtained from ischemia to 30 min of reperfusion. Area at
risk measured at 72 h post IR is expressed as % of LV. NA = Not Applicable.
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level were in any case assessed in the L-T3S rats. These findings indicate that a decreased post IR T3 
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Figure 1. Effect of L-T3S on cardiac functional recovery and mitochondrial activity 72 h post IR. (A) 
LV end systolic diameter (LVESd) (left panel), fractional shortening (FS) (medium panel) and systolic 
anterior wall thickening (SAWT) (right panel); (B) Non linear fitting (sigmoid) relating the ∆FT3 
values (difference between 3 days post IR and basal) to systolic anterior wall thickening (SAWT) in 
IR-LT3 and IR-NT3; and (C) mitochondrial function assessed in the LV area at risk (AAR): citrate 
synthase (CS) normalized cytochrome c oxidase (CcOx) activity (left panel) and ATP production 
(right panel). Data are expressed as mean ± SE; n = 5 in each group; * p ≤ 0.005. 
2.3. Mitochondrial Proteome 
A proteomic study was then performed to assess if the physiological and biochemical differences 
observed between IR-LT3S and IR-NT3 rats might be related to quantitative changes in the cardiac 
mitochondrial proteome. To this end, mitochondrial protein profiling from sham, IR-NT3 and  
Figure 1. Effect of L-T3S on cardiac functional recovery and mitochondrial activity 72 h post IR.
(A) LV end systolic diameter (LVESd) (left panel), fractional shortening (FS) ( edium panel) and
systolic anterior wall thickening (SAWT) (right panel); (B) Non linear fitting (sigmoid) relating the
∆FT3 values (difference between 3 days post IR and basal) to systolic anterior wall thickening (SAWT)
in IR-LT3 and IR-NT3; and (C) mitochondrial function assessed in the LV area at risk (AAR): citrate
synthase (CS) normalized cytochrome c oxidase (CcOx) activity (left panel) and ATP production (right
panel). Data are expressed as mean ˘ SE; n = 5 in each group; * p ď 0.005.
To evaluate if this alteration can be associated with a greater degree of mitochondrial impairment
in the AAR of L-T3S rats, we next determined cytochrome c oxidase activity and ATP production.
As shown in Figure 1C, both ischemia injured groups showed reduced citrate synthase-normalized
cytochrome c activity, as well as reduced rate of ATP production, but the lowest level were in any
case assessed in the L-T3S rats. These findings indicate that a decreased post IR T3 level is associated
with poorer mitochondrial activity and energy production.
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2.3. Mitochondrial Proteome
A proteomic study was then performed to assess if the physiological and biochemical differences
observed between IR-LT3S and IR-NT3 rats might be related to quantitative changes in the cardiac
mitochondrial proteome. To this end, mitochondrial protein profiling from sham, IR-NT3 and
IR-LT3S rats were obtained. The principal mitochondrial proteins were identified, as shown in the
Supplementary Material (Figure S1). Multiple comparisons were performed to identify differentially
expressed proteins. Of the total 546 identified proteins, 138 mitochondrial proteins exhibited
significant changes and were grouped according to their function using the published literature
and Uniprot database (Nucleic Acids Res. 43:D204-D212, 2015). Figure 2A shows the percentage
representation of different protein groups/functions (clusters) significantly changed between IR-LT3S
and IR-NT3. Twenty-five percent of altered proteins are implicated either in mitochondrial quality
control (21%) or in cell death (4%). It is particularly notable that the remaining 75% belongs to
functional groups that are involved in ATP synthesis.
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Figure 2. Mitochondrial proteomic analysis obtained at 72 h post IR. (A) Pie chart showing percentage 
of differentially expressed proteins grouped according to their function in IR-NT3 vs. IR-LT3; and (B) 
clustering of differentially expressed proteins in IR-LT3S vs. IR-NT3 generated by IPA software. 
Networks related to diseases, functions and canonical pathways were generated based on the 
information stored in IPA Knowledge base. Network nodes are named by correspondent Gene Codes. 
The color assigned to node name indicate the level of proteins expression: red for up-regulated, blue 
for down-regulated and black for no change in IR-NT3 vs. IR-LT3S respectively. Gene acronyms are listed 
in the abbreviation list. 
Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com/products/pathways_analysis.html, 
Qiagen, Venlo, Holland) was used to confirm the functional protein grouping of differentially 
expressed proteins in IR-NT3 vs. IR-LT3S and to relate them to disease. As shown in Figure 2B, the 
protein clusters play critical roles in mitochondrial activity and dysfunction, and in disease 
etiopathology (cardiomyopathy). Selected proteins from each functional group are reported in 
Figures 3–6 and described below (Tables S1–S5 for the complete list). 
2.4. Mitochondrial Quality Control and Cell Death 
IR induced a significant upregulation of stress-responsive proteins (Figure 3). Notably, IR-NT3 
rats exhibited the highest level of heat shock proteins (HSP), including HSP27, HSP71, HSP90 and  
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Figure 2. itochondrial proteomic analysis obtained at 72 h post IR. (A) Pie chart showing percentage
of differentially expressed proteins grouped according to their function in IR-NT3 vs. IR-LT3;
and (B) clustering of differentially expressed proteins in IR-LT3S vs. IR-NT3 generated by IPA
soft are. Networks related to diseases, functions and canonical pathways were generated based
on the information stored in IPA Knowledge base. Network nodes are named by correspondent
Gene Codes. The color assigned to node name indicate the level of proteins expression: red for
up-regulated, blue for own-regulated and black for no change in IR-NT3 vs. IR-LT3S respectively.
Gene acronyms are listed in the abbreviation list.
Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com/products/pathways_analysis.html,
Qiagen, Venlo, Holland) was used to confirm the functional protein grouping of differentially
expressed proteins in IR-NT3 vs. IR-LT3S and to relate them to disease. As shown in Figure 2B,
the protein clusters play critical roles in mitochondrial activity and dysfunction, and in disease
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etiopathology (cardiomyopathy). Selected proteins from each functional group are reported in
Figures 3–6 and described below (Tables S1–S5 for the complete list).
2.4. Mitochondrial Quality Control and Cell Death
IR induced a significant upregulation of stress-responsive proteins (Figure 3). Notably, IR-NT3
rats exhibited the highest level of heat shock proteins (HSP), including HSP27, HSP71, HSP90 and
α-crystallin (Cryab) along with a greater increase of DNA-repair-associated proteins (40s ribosomal
protein S3, Rps3; and O-acetyl-ADP-ribose deacetylase, Macrod1) (Figure 3). By considering ROS
scavenging system, six antioxidant enzymes were found to be upregulated in IR-NT3 group vs.
both sham and IR-LT3S groups, including isoforms of aldehyde deidrogenase (Aldh6a and Aldh2),
peroxiredoxines (Prdx2 and Prdx5) and superoxide dismutases (Sod1 and Sod2) (Figure 3). On the
contrary, in the IR-LT3S group the level of the antioxidant enzymes was comparable to the sham
group (Figure 3).
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Figure 3. Differentially expressed proteins involved in cell death and mitochondrial quality control  
in response to stress. Data are expressed as median and interquartile range. * p vs. sham < 0.017;  
# p vs. IR-LT3S < 0.017. Protein acronyms are listed in the abbreviation list. 
IR also differently affected proteins involved in mitochondrial-mediated cell death/survival 
processes. In particular, in the IR-NT3 group the phosphate carrier (Slc25a3) was downregulated 
versus both the sham and the IR-LT3S. This protein remained unchanged in the IR-LT3S rats with 
respect to the sham group. The increase of voltage dependent anion selective channel protein 1 
(VDAC1) observed in IR-LT3S was prevented in IR-NT3 group. The protective transglutaminase 2 
(TGM2) was upregulated in both IR groups, with the highest values shown by IR-NT3 rats (Figure 3). 
Overall these data suggest that mitochondria of IR-NT3 rats possess higher protein quality 
control and greater defensive capacity to face IR injury. 
2.5. Cellular Energy Metabolism 
In accordance with well known post IR cardiac metabolic impairment, protein expression in IR 
rats was altered at crucial points in cellular energy metabolism. 
Pre-TCA and TCA cycle enzyme isoforms were upregulated in response to IR, but the highest 
levels were measured in the IR-NT3 rats (Figure 4). The main modulated proteins are involved in: (1) 
anaplerotic reaction and malate/aspartate shuttle (aspartate aminotransferase, Got2); (2) regulation 
of pyruvate entry through TCA (pyruvate dehydrogenase alpha 1/1, Pdha1/1; and pyruvate 
dehydrogenase kinase 1 and 2, Pdk1 and Pdk2); (3) TCA cycle (citrate synthase, CS; aconitate 
hydratase Aco2; isocitrate dehydrogenase (NADP) Idh2; and fumarate hydratase, Fh); and (4) 
substrate level phosphorylation (E2 and E3 component of the 2-oxoglutarate dehydrogenase Dlst and 
Dld; and succinyl-CoA synthetase, Sucla 2 and Suclg1) (Figure 4). 
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Figure 3. Differentially expressed proteins involved in cell death and mitochondrial quality control in
response t ress. Data are xpress d as median and interquartile range. * p vs. sham < 0.017; # p vs.
IR-LT3S < 0.017. Protein acronyms are listed in he abbrevi tion list.
IR also differently affected protei lved in mitochondrial-mediated cell death/survival
processes. In particular, in the IR-NT3 group the phosphate carrier (Slc25a3) was downregulated
versus both the sham and the IR-LT3S. This protein remained unchanged in the IR-LT3S rats with
respect to the sham group. The increase of voltage dependent anion selective channel protein 1
(VDAC1) observed in IR-LT3S was prevented in IR-NT3 group. The protective transglutaminase 2
(TGM2) was upregulated in both IR groups, with the highest values shown by IR-NT3 rats (Figure 3).
Overall these data suggest that mitochondria of IR-NT3 rats possess higher protein quality
control and greater defensive capacity to face IR injury.
2.5. Cellular Energy Metabolism
In accordance with well known post IR cardiac metabolic impairment, protein expression in IR
rats was altered at crucial points in cellular energy metabolism.
Pre-TCA and TCA cycle enzyme isoforms were upregulated in response to IR, but the
highest levels were measured in the IR-NT3 rats (Figure 4). The main modulated proteins are
involved in: (1) anaplerotic reaction and malate/aspartate shuttle (aspartate aminotransferase, Got2);
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(2) regulation of pyruvate entry through TCA (pyruvate dehydrogenase alpha 1/1, Pdha1/1; and
pyruvate dehydrogenase kinase 1 and 2, Pdk1 and Pdk2); (3) TCA cycle (citrate synthase, CS;
aconitate hydratase Aco2; isocitrate dehydrogenase (NADP) Idh2; and fumarate hydratase, Fh); and
(4) substrate level phosphorylation (E2 and E3 component of the 2-oxoglutarate dehydrogenase Dlst
and Dld; and succinyl-CoA synthetase, Sucla 2 and Suclg1) (Figure 4).I t. J. Mol. Sci. 2015, 16, page–page 
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Figure 4. Differentially expressed proteins involved in TCA cycle and pre TCA cycle.  
Data are expressed as median and interquartile range. * p vs. sham < 0.017; # p vs. IR-LT3S < 0.017. 
Protein acronyms are listed in the abbreviation list. 
Similarly to pre-TCA and TCA, IR induced an increase of protein subunits involved in  
fatty acid metabolism (Figure 5). The highest levels were found in IR-NT3 rats and the most highly 
expressed isoforms were involved in: (1) β oxidation and lipid biosynthesis (2,4-dienoyl CoA 
reductase 1, Decr1; acetyl-coenzyme A dehydrogenase medium and short chain, Acadm and Acads;  
δ(3,5)-δ(2,4)-dienoyl-CoA isomerase, Ech1; enoyl-CoA hydratase, Echs1; hydroxyacyl-coenzyme A 
dehydrogenase, Hadh; and acyl-CoA synthetase family member 2, Acsf2); (2) regulation of 
intracellular levels of acyl-CoAs free fatty acids and CoASH (Protein Acot 13, LOC683884); and (3) 
regulation of fatty acid transport and fatty acid substrate utilization (fatty acid-binding protein, 
Fabp3; and acyl-CoA thioesterase 2, Acot2) (Figure 5). 
 
Figure 5. Differentially expressed proteins involved fatty acid metabolism. Data are expressed as 
median and interquartile range. * p vs. sham < 0.017; # p vs. IR-LT3S < 0.017. Protein acronyms are 
listed in the abbreviation list. 
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Figure 4. Differentially expressed proteins involved TCA cycle and pre TCA cycle. Data are
expressed as median and interquartile ra ge. * p vs. sh m < 0.017; # p vs. IR-LT3S < 0.017. Protein
acronyms are listed in the abbreviation list.
Similarly to pre-TCA and TCA, IR induced an increase of protein subunits i volved in fatty
acid metabolism (Figure 5). The highest levels were found in IR-NT3 rats and the most highly
expressed isoforms were involved in: (1) β oxidation and lipid biosynthesis (2,4-dienoyl CoA
reductase 1, Decr1; acetyl-coenzyme A dehydrogenase medium and short chain, Acadm and Acads;
δ(3,5)-δ(2,4)-dienoyl-CoA isomerase, Ech1; enoyl-CoA hydratase, Echs1; hydroxyacyl-coenzyme
A dehydrogenase, Hadh; and acyl-CoA synthetase family member 2, Acsf2); (2) regulation of
intracellular levels of acyl-CoAs free fatty acids and CoASH (Protein Acot 13, LOC683884); and
(3) regulation of fatty acid transport and fatty acid substrate utilization (fatty acid-binding protein,
Fabp3; and acyl-CoA thioesterase 2, Acot2) (Figure 5).
IR influenced also the content of several enzymes regulating other metabolic reactions (Figure 6).
As for TCA and fatty acid oxidation, the highest levels were measured in IR-NT3 group. Among
them, of particular interest for the post IR functional r covery are those involved in lactate metabolism
and clearance, glycolysis and glycogenolysis (L-lactate dehydrogenase B chain, Ldhb; pyruvate
kinase, MOR4B8; phosphoglycerate kinase 1, Pgk1; and glycogen phosphorylase, Pigb) (Figure 6).
Finally, IR-NT3 rats exhibited increased levels of the mitochondrial creatine kinase isoform (CKmt2),
a protein that was more severely decreased in IR-LT3S group and that plays a critical role in energy
homeostasis. (Figure 6).
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Figure 5. Differentially expressed proteins involved fatty acid metabolism. Data are expressed as
median and interquartile range. * p vs. sham < 0.017; # p vs. IR-LT3S < 0.017. Protein acronyms are
listed in the abbreviation list.
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IR influenced also the content of several enzymes regulating other metabolic reactions  
(Figure 6). As for TCA and fatty acid oxidation, the highest levels were measured in IR-NT3 group. 
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kinase, MOR4B8; phosphoglycerate kinase 1, Pgk1; and glycogen phosphorylase, Pigb) (Figure 6). 
Finally, IR-NT3 rats exhibited increa ed levels of the mitochondrial cr atine kinase isoform (CKmt2), 
a protein that was more severely decreased in IR-LT3S grou  and that plays a critical role i  energy 
homeostasis. (Figure 6). 
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In line with ATP production data, these findings suggest that, with respect to IR-LT3S rats,  
IR-NT3 rats present a greater ability to provide metabolic intermediates for TCA and to oxidize FFA, 
glucose and glycogen in order to sustain greater ATP production. 
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recovery and lower mitochondrial activity impairments in the injured LV myocardium. Moreover, 
proteomic profiling in IR-NT3 and IR-LT3S rats revealed a different modulation of mitochondrial 
proteins critically involved in the regulation of mitochondrial activity and cardiomyocyte survival, 
as suggested by IPA (see Figure 2B). The main proteomic results are discussed below according to 
the functional protein grouping. 
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Mitochondrial reactive oxygen species (ROS) production following IR leads to extensive  
damage to different types of mitochondrial molecules resulting in mitochondrial dysfunction [29]. 
Different strategies of mitochondrial quality control have evolved to counteract the adverse effects 
resulting from oxidative stress [30]. Among these processes, repair of damaged molecules, refolding  
of misfolded proteins, ROS scavenging and removal of excessively damaged mitochondria play  
a key role. 
Protein folding and repair are regulated by specialized proteins, termed chaperones, which 
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proteomic profiling in IR-NT3 and IR-LT3S rats revealed a different modulation of mitochondrial
proteins critically involved in the regulation of mitochondrial activity and cardiomyocyte survival, as
suggested by IPA (see Figure 2B). The main proteomic results are discussed below according to the
functional protein grouping.
3.1. Mitochondrial Quality Control and Mitochondrial-Mediated Cell Death
3.1.1. Mitochondrial Quality Control
Mitochondrial reactive oxygen species (ROS) production following IR leads to extensive damage
to different types of mitochondrial molecules resulting in mitochondrial dysfunction [29]. Different
strategies of mitochondrial quality control have evolved to counteract the adverse effects resulting
from oxidative stress [30]. Among these processes, repair of damaged molecules, refolding of
misfolded proteins, ROS scavenging and removal of excessively damaged mitochondria play a
key role.
Protein folding and repair are regulated by specialized proteins, termed chaperones, which
include heat-shock proteins (HSPs) [31]. The protective functions of HSP70, HSP90, HSP 27 and
α-crystallin B against IR injury was extensively investigated in previous studies using transgenic
animals and isolated cardiac myocyte-derived cells [32–34]. Similarly, overexpression of the small
HSPs α-crystallin B and HSP27 diminished the reversible damage after simulated or myocardial
ischemia [35–37].
Accordingly, in our study, the post IR retention of physiological T3 levels was associated with
a higher content of HSP71, HSP90, HSP27 and α-crystallin B, which was paralleled by preserved
mitochondrial function.
Mitochondrial DNA is another target of IR. Mitochondrial DNA damage plays a key role in post
IR disease progression, which highlights the importance of efficient repair machinery [38]. In our
model of IR, two proteins implicated in DNA damage repair namely 40s ribosomal protein S3 (rpS3)
and O-acetyl-ADP-ribose deacetylase (MACROD1) were found to be up-regulated in IR-NT3 group
with respect to IR-LT3S. These proteins act synergistically through different modes of action to afford
cardioprotection [39–41].
Antioxidant defenses are another important class of mitochondrial quality control molecules
that were differentially modulated by post IR FT3 levels. Among them, Aldh2 protects the heart
against ischemic injury through detoxification of toxic aldehyde and a differential regulation of
autophagy [42,43], while peroxiredoxins and superoxide dismutases play a key cardioprotective role
through oxide detoxification [44–47].
We propose that the higher level of quality control proteins observed in the IR-NT3 group
promotes better repair of post IR mitochondrial damage, which is essential for preserved
mitochondrial activity.
3.1.2. Cell Fate
IR-induced mitochondrial impairments favor the formation of mitochondrial pores that open
in a process known as mitochondrial permeability transition leading to apoptosis and necrosis.
Inhibition of this process is cardioprotective in both patients and animal models [48,49]. In our study,
the two mitochondrial permeability transition activators (namely, the phosphate carrier and Vdac1)
were less expressed in the IR-NT3 group than in IR-LT3S. These data are in line with our previous
observations [27] that LT3S correction by T3 replacement in the post IR setting limits mitochondrial
membrane depolarization and cell death and reinforces the hypothesis of a key role of post-IR T3
levels in cardiac recovery.
When mitochondrial injuries overwhelm molecular repair capacity and antioxidant defenses,
removal of damaged mitochondria through mitophagy is a protective strategy to avoid cell death.
Our proteomic profiling showed in the IR-LT3 group the highest level of tissue tranglutaminase 2
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(Tgm2), a cardioprotective effector that participates in the maintenance of the intact mitochondrial
respiratory function and in the clearance of damaged mitochondria [50,51].
3.2. Oxidative Phosphorylation
The oxidative phosphorylation system (OXPHOS) in the mitochondrial inner membrane
carries out the central biological process of cardiac energy metabolism. Thus, the alteration
of major OXPHOS proteins is responsible for modifying all the cardiac energy metabolism and
performance. As expected, we found in both injured groups a significant dysregulation of all
ETC and ATP synthesis complexes, the lowest levels being measured in IR-NT3 group. The
apparently contradictory result of lower OXPHOS protein levels in the presence of better preserved
functional recovery and mitochondrial activity observed in the IR-NT3 group, may have several
explanations. First, with the exception of complex II, all ETC complexes can associate themselves in
supercomplexes, known as respirasomes, that organize electron flux to optimize the use of available
substrates [52]. Mitochondrial defects can arise from supramolecular assembly rather than from the
individual components of the ETC [6]. We speculate that the higher level of quality control proteins
in IR-NT3 rats guarantees the assembly of intact, correctly-folded mitochondrial components in more
functional macromolecular complexes, which may explain higher ATP production in the presence
of lower ETC protein content. Second, post-translational modifications (PTMs) have emerged as
powerful regulators of mitochondrial function and in particular of the mitochondria-encoded subunit
1 of the complex IV [53–55]. We might speculate that different post IR T3 levels may have induced
different post-translational modifications (PTMs) in ETC complexes. Our proteomic approach was
not intended to analyze PTMs, further dedicated studies are needed to explore this critical issue.
3.3. Pre TCA, TCA Cycle
The tricarboxylic acid cycle (TCA) forms a major metabolic hub and as such it is involved
in many disease states involving energetic imbalance. In hypoxic conditions such as in the post
IR setting, when OXPHOS is impaired, the TCA supplies high-energy phosphates through matrix
substrate-level phosphorylation catalyzed by the succinyl coenzyme A synthetase [56,57].
It has been demonstrated that reduction of glycogen turnover and depletion of TCA substrates
contributes to impaired contractile function of ischemia/reperfused myocardium, and that TCA
intermediates, along with essential substrates, such as glucose, lactate, and pyruvate, are necessary to
ensure functional recovery with reperfusion. [58,59]. A central role in substrate level phosphorylation
is played by α-ketoglutarate dehydrogenase, that supply succinyl-CoA to succinyl coenzyme A
synthetase, and by malate-aspartate shuttle, that is involved in anaplerotic supply of substrate to
TCA [56].
In our study the decreased OXPHOS protein content following the ischemic injury was
counterbalanced by an increase in pre-TCA, and TCA cycle enzymes, as well as in glycolytic enzymes.
This tendency was more evident in the presence of preserved post IR FT3 and in particular regarded
the enzymes involved in anaplerotic reaction and in the substrate level phosphorylation. These
data suggest that the preserved TH level may play a key role in favoring mitochondrial anaerobic
production of ATP. Our data are in agreement with previous findings in multiple animal models
showing that T3 supplementation modulates pyruvate entry into the TCA, thereby providing the
energy support for improved cardiac function after reperfusion [60,61]. We speculate that the
effects of preserved physiological levels of T3 on α-ketoglutarate dehydrogenase might improve
post IR cardiac efficiency. Indeed, supply of α-ketoglutarate during blood cardioplegia attenuated
ischemic injury in patients undergoing coronary operations [62,63]. Similarly, T3 administration
in patients with L-T3S induced by cardiopulmonary bypass improved postoperative ventricular
function, reduced the need for treatment with inotropic agents and mechanical devices, and decreased
the incidence of myocardial ischemia [64].
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3.4. Fatty Acids Metabolism
In healthy hearts, >70% of the cardiac energy is accounted for by oxidation of fatty acids (FAs)
and the remainder by glucose oxidation. However, the heart changes its substrate preference from
FAs towards glucose as remodeling develops in response to diverse stresses including IR [65]. This
metabolic shift may be an adaptive mechanism under acute stress condition such as IR, because
it lowers oxygen consumption. On the other hand, glucose oxidation yields far less ATP than
FAs. Insufficient ATP production is likely to increase the susceptibility of post-infarct hearts to
cardiomyocyte death and contractile dysfunction [66]. Accordingly, reversal of metabolic shift in
post IR remodeling markedly improved contractile function [67].
Here we report that retention of physiological post IR T3 levels in the early post IR phase is
associated with the upregulation of several proteins involved in FA oxidation.
If confirmed through mechanistic inferences, these data might support and extend to
cardiovascular pathologies, such as IR, the notion that changes of TH levels affect the myocardial
mitochondrial bioenergetic capacity [68].
3.5. Study Limitations and Concluding Remarks
The results, obtained in a small population of animals, are associative and, in the absence
of an intervention group (for example ischemia/reperfusion animals treated with T3), at present
we are unable to infer any cause and effect relationship neither between post IR T3 level
and cardiac/mitochondrial function, nor between proteomic remodeling and cardiac impairment.
Moreover, the assumption that circulating T3 levels are a substitute of myocardial T3 content derives
from data of previous studies [27,28] rather than a direct measurement in the present study.
Nevertheless, our data clearly indicate specific changes in mitochondrial protein expression
in relation to different post IR circulating T3 level. Retention of physiological T3 concentration is
associated with the upregulation of proteins with functional relevance in rescue of mitochondrial
integrity and in optimization of substrate utilization. These differences along with the better recovery
of post IR cardiac function and mitochondrial activity in the NT3 rats prompt us to speculate that
a condition of L-T3S in the early setting of the post IR wound healing might affect mitochondrial
function and contribute to adverse remodeling.
4. Material and Methods
4.1. Animal Procedure
The study was performed in accordance with the European Directive (2010/63/UE) and the
Italian law (D.L 26/2014), and the protocol was approved by the Animal Care Committee of the
Italian Ministry of Health (Endorsement n.240/2011-B, 9 November 2011). All surgery was performed
under anaesthesia, and all efforts were made to minimize suffering. The study design is depicted in
the flow chart reported in Figure 7. A total of 24 male Wistar rats were used in the study. Five rats
were assigned in the sham group and 19 underwent IR. Out of 19 animals subjected to LAD occlusion,
two died during surgery due to irreversible ventricular fibrillation following the IR protocol.
Myocardial infarction and reperfusion was produced by 30 min ligation of the left descending
coronary artery (LAD) followed by reperfusion of adult male Wistar rats 12–15 weeks old and
weighing 310 ˘ 3 g using a technique described in detail elsewhere [27]. A standard limb D1–D3
electrocardiogram (ECG) was continuously monitored during surgery up to 60 min.
In all cases ischemia was confirmed by ST segment elevation in the ECG and visually assessed
regional cardiac cyanosis. In addition, occurrence of arrhythmias both during ischemia and at
reperfusion was also recorded: arrhythmias were classified according to the Lambeth Conventions.
A scoring system was used to classify their severity as previously described [69].
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Figure 7. (A) Flow chart showing the study design. Seventy-two hours post IR, five rats developed a 
low T3 state (IR-LT3S) while 12 maintained normal FT3 plasma levels (IR-NT3 group). All five rats of 
the IR-LT3S group were used, and for a balanced statistical analysis between groups of equal 
numbers, five were randomly enrolled out of the 12 IR-NT3 rats; (B) Scatter-plot showing FT3 plasma 
levels in the IR-LT3S group (squares) and NT-3 group (circles) at baseline (filled symbols) and three 
days post IR (empty symbols). Different colors represent different rats. Continuous and dashed lines 
indicate the mean values before and after IR respectively. 
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The severity score of ventricular arrhythmias was used as index of ischemia damage and a
score level equal or greater than three was adopted as inclusion criteria in the study. A group of
sham-operated rats was used as control. Three days after surgery hearts were arrested in diastole by
a lethal KCl injection. Cardiac tissue samples were obtained from the core of the ischemic reperfused
region (area at risk, AAR) of LV as describe elsewhere [27]. In sham-operated animals tissues were
harvested from corresponding regions. Samples from each area were immediately processed for
mitochondria isolation. Rats undergone I/R were allocated to two groups according to the percent
decrease of T3 circulating levels measured at 72 h after surgery against the basal value. In particular,
a reduction ě20% of the basal level of T3 measured 3 days after surgery was used as cut-off value to
enroll animals in the low T3-state group (IR-LT3S). All the other rats were included in the normal T3
group (IR-NT3).
4.2. Echocardiography Study
Echocardiographic studies were performed three days after infarction with a portable ultrasound
system (MyLab 25, Esaote SpA, Genova, Italy) equipped with a high frequency linear transducer
(LA523, 12.5 MHz). Images were obtained from the sedated animal, from the left parasternal view.
Short-axis two-dimensional view of the left ventricle (LV) was taken at the level of papillary muscles
to obtain M-mode recording. Anterior (ischemia-reperfused) and posterior (viable) end-diastolic and
end-systolic wall thicknesses, systolic wall thickening, and LV internal dimensions were measured
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following the American Society of Echocardiography guidelines. Parameters were calculated as mean
of the measures obtained in three consecutive cardiac cycles. The global LV systolic function was
expressed as fractional shortening (FS%).
4.3. Morphometric Analysis to Determine the Area at Risk
The area at risk (AAR) was determined as previously described [27]. Briefly, three days after
surgery, the LAD was re-tied with the suture left in its original position and 1 mL 1% Evan’s
blue (Sigma Aldrich, Saint Louis, MO, USA) was injected in the inferior cava vein to identify the
myocardial AAR as unstained. Next, the heart, arrested in diastole, was excised and cut in transversal
and parallel slices about 2 mm thick. LV area and the AAR, (expressed as percentage of the LV) from
each slice were measured using Image J software (open source image processing program).
4.4. Serum and Tissue Thyroid Hormone Levels
Two mL of blood were collected from the femoral vein both 3–5 days before (basal) and 3 days
after LAD occlusion (terminal endpoint) in anesthetized animals. Serum free T3 (FT3) and free T4
(FT4) were assayed as previously described [27].
4.5. Mitochondria Isolation
Mitochondria were purified from LV fresh tissue according to the manufacturer’s protocol
(MITO-ISO1; Sigma Aldrich, Saint Louis, MO, USA) and as previously described [26]. Briefly, cardiac
tissue was homogenized in buffer containing 10 mM 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic
acid, N-(2-Hydroxyethyl)piperazine-N1-(2-ethanesulfonic acid) (HEPES, Sigma
Aldrich), 200 mM mannitol (Sigma Aldrich), 70 mM sucrose and 1mM Ethylene
glycol-bis(2-aminoethylether)-N,N,N1,N1-tetraacetic acid(EGTA) (PH 7.5, Sigma Aldrich) and
centrifuged at 2000ˆ g at 4 ˝C for 5 min. The supernatant was collected and centrifuged at 11,000ˆ g
at 4 ˝C for 20 min. The pellet was suspended in storage buffer at pH 7.5 containing 10 mM HEPES,
250 mM sucrose (Sigma Aldrich), 1 mM ATP (Sigma Aldrich), 0.08 mM ADP (Sigma Aldrich), 5 mM
sodium succinate (Sigma Aldrich), 2 mM K2HPO4 (Sigma Aldrich) and 1 mM DTT (Sigma Aldrich)
and stored at ´80 ˝C until use. An aliquot of the suspended pellet was assayed for protein content
with the Pierce bicinchoninic protein assay kit (Sigma Aldrich).
4.6. Mitochondrial Enzyme Activity Assays
Mitochondrial function was expressed as the ratio between the activity of the cytochrome c
oxidase-1 (CcOX-1) and that of citrate synthase (CS) to normalize for mitochondrial mass. Enzyme
activity was assessed in 1mL cuvette by using spectrophotometric assay kit according to the
manufacturer’s protocols (CYTOC-OX1 and CS0720, Sigma Aldrich) and as previously described [27].
All assays were performed in triplicate.
4.7. Measurements of ATP Production in Isolated Mitochondria
ATP synthesis rates were measured in mitochondrial fractions with the ATP Determination
Kit A22066 (Thermo Scientific, Waltham, MA, USA) as previously described [27]. The assays were
performed in triplicate in 96 well plate in a volume of 150 µL containing10 µg mitochondria protein,
0.25 M sucrose, 50 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 10 mM KH2PO4, 1 mM pyruvate,
1 mM malate. 1 mM ATP-free ADP and a solution of 0.5 mM luciferin and 0.25 µg/mL luciferase
were added with the injectors integrated in the plate reader (Infinite M200 PRO, TECAN, Männedorf,
Switzerland). The slope of luminescence increase was determined in the first 48 s after injection
of luciferase reagent and ADP, and it was converted to ATP concentration using a standard curve
according to the manufacturer’s instruction.
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4.8. Proteomics Sample Pre-Processing
For proteomic analyses the crude mitochondrial fraction was further purified on Percoll gradient
as previously described with some modification [70]. Briefly, mitochondria were resuspended in
1 mL of 15% Percoll and layered on preformed gradient consisting of 22% Percoll (3 mL) layered
over 50% Percoll (1 mL). Following centrifugation of the gradient at 90,000ˆ g for 40 min, the
mitochondrial fraction that accumulated at the lower interface (between the 50% and 22% Percoll
layers) was collected and diluted with PBS (1:8). After 2 washing step in PBS, the pellet was lysed
in TRIS HCl 5 mM pH = 8.1, acetonitrile 10% (Romil, Cambridge, UK) and protease inhibitor and
sonicated in ice. Protein concentration was determined by bicinchoninic acid assay (Pierce, Thermo
Scientific, Waltham, MA, USA). About 20 µg of protein were diluted in Ammonium Bicarbonate
25 mM, reduced with dithiothreitol DTT 5 mM at 80 ˝C for 30 min and alkylated using iodoacetamide
10 mM at 37 ˝C for 20 min. Digestion was performed incubating overnight with 1:100 trypsin
(Roche, Basel, Switzerland):substrate at 37 ˝C. Peptides solution was then loaded on a C18 cartridge
in order to eliminate debris and filtered with 0.22 µm filter. Peptide mix was diluted to 100 µL by 2%
ACN/0.1% FA.
4.9. nanoLC-MS/MS SWATH-Based Analysis
Chromatographic separation of peptides was performed using a nano-HPLC system (Eksigent,
ABSciex, Washington, DC, USA). The loading pump pre-concentrated the sample in a pre-column
cartridge (PepMap-100 C18 5 µm 100 A, 0.1 ˆ 20 mm, Thermo Scientific, Waltham, MA, USA) and
then separated in a C18 PepMap-100 column (3 µm, 75 µm ˆ 250 mm, Thermo Scientific) at a flow
rate of 300 nL¨min´1. Runs were performed with eluent A (Ultrapure water, 0.1% Formic acid)
under 60 min linear gradient from 5% to 40% of eluent B (Acetonitrile, 0.1% Formic acid) followed by
10 min of a purge step and 20 min re-equilibration step. Peptides eluted from chromatography were
directly processed using 5600 TripleTOF™ mass spectrometer (ABSciex) equipped with a DuoSpray™
ion source (ABSciex). Data were acquired using the new Sequential Window Acquisition of all
THeoretical Mass Spectra (SWATH™) method for shotgun data independent MRM quantification.
For library, MS/MS data were processed with ProteinPilot™ Software (ABSciex). The false
discovery rate (FDR) analysis was done using the integrated tools in ProteinPilot software (ABSciex,
Washington, DC, USA) and a confidence level of 95% was set.
The label free statistical comparative analysis was performed using PeakView4.5 Software
(ABSciex) with MS/MS(ALL) with SWATH™ Acquisition MicroApp 2.0 and MarkerViewTM
(ABSciex). Retention time alignment was obtained using selected peptides from top score protein.
Processing settings were: 7 peptides per protein, 7 transitions per peptide, 92% peptide confidence
(according to Paragon algorithm result) and 5% FDR; XIC (Extracted-Ion Chromatogram) options:
extraction window 10 min, width 50 ppm and 0.1 Da. Normalization of the sample content was
done using a global normalization of profiles (based on total protein content). Principal Component
Analysis (PCA) was performed in order to evidence groupings among the data set. SWATH
strategy generate time-resolved fragment ion spectra sufficiently specific to confidently identify query
peptides which are quantified with a consistency and accuracy comparable with that of selected
reaction monitoring, the gold standard proteomic quantification method [71]. This means that
differential expression analysis of SWATH data allows the profiling of disease-related proteomes with
a high degree of reproducibility and confidence providing self-validated data [72].
4.10. Statistical Analysis
Results are given as mean + SEM unless otherwise stated. Since the post IR circulating free
T3 (FT3) levels have been used to allocate rats to different groups, we verified the distribution of
this parameter for normality (Kolmogorov-Smirnov) before inferential statistic analysis. Differences
among the three groups of rats were analyzed by a one-way ANOVA followed by a Bonferroni
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test once normality had been proven (Kolmogorov-Smirnov test). Differences were considered
statistically significant at a value of p < 0.05. For proteomic analyses, a non-parametric test
(Kruskall-Wallis) was run considering all the three groups. Thereafter, a Mann-Whitney U-test
(adjusting the α-level by Bonferroni inequality) was used to check differences between groups two
by two (differences were considered statistically significant at a value of p < 0.017). The significant
proteins resulting from the Mann-Whitney U-test comparison between IR-NT3 and IR-LT3 (n = 82)
were used as input dataset for IPA and networks were created for the most significant linked diseases
and functions. Additionally, proteins involved in TCA cycle pathway were shown (Figure 2B).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/
16/11/25973/s1.
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Abbreviations
Acaa2 = 3-ketoacyl-CoA thiolase.
Acadl = Long-chain specific acyl-CoA dehydrogenase.
Acadm = Acetyl-Coenzyme A dehydrogenase, medium chain.
Acads = Acetyl-Coenzyme A dehydrogenase, short chain.
Acat1 = Acetyl-CoA acetyltransferase.
Aco2 = Aconitate hydratase.
Acot2 = Acyl-CoA thioesterase 2.
Acsf2 = Acyl-CoA synthetase family member 2.
Aldh2 = Aldehyde dehydrogenase.
Aldh6a1 = Aldehyde dehydrogenase family 6, isoform CRA.
Ckmt2 = Creatine kinase mitochondrial.
Cpt1b = Carnitine O-palmitoyltransferase 1.
Cryab = α-crystallin B chain.
Cs = Citrate synthase.
Decr1 = 2,4-dienoyl CoA reductase 1.
Dld = Dihydrolipoyl dehydrogenase.
Dlst = Dihydrolipoamide S-succinyltransferase.
Ech1 = δ(3,5)-δ(2,4)-dienoyl-CoA isomerase.
Echs1 = Enoyl-CoA hydratase.
Eci1 = Dodecenoyl-Coenzyme A δ isomerase (3,2 trans-enoyl-Coenzyme A isomerase).
Ecl1 = Extender of the chronological lifespan protein 1.
Ecl2 = Extender of the chronological lifespan protein 2.
Fabp3 = Fatty acid-binding protein.
Fh = Fumarate hydratase 1.
Got2 = Aspartate aminotransferase.
Hadh = Hydroxyacyl-coenzyme A dehydrogenase.
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Hibadh = 3-hydroxyisobutyrate dehydrogenase.
Hsc70 = Heat shock cognate 71 kDa.
Hspb6 = Heat shock protein α-crystallin-related-B6.
Hsp90ab1 = Heat shock protein HSP 90-α class B, member 1.
Hspb1 = Heat shock 27 kDa protein 1.
Hspd1 = Heat shock protein 60 kDa.
Hspe1 = Heat shock 10kDa protein 1.
Idh2 = Isocitrate dehydrogenase (NADP).
Ivd = Isovaleryl-CoA dehydrogenase.
Ldhb = L-lactate dehydrogenase B chain.
LOC683884 = Protein Acot13.
Lrpprc = Leucine-rich PPR.
Ndufab1 = NADH dehydrogenase (ubiquinone) 1, α/β subcomplex, 1.
Macrod1 = O-acetyl-ADP-ribose deacetylase MACROD1.
Mdh2 = Malate dehydrogenase.
MOR4B8 = Pyruvate kinase.
Ogdh = 2-oxoglutarate dehydrogenase.
Oxct1 = Succinyl-CoA:3-ketoacid coenzyme A transferase 1.
Pdha1/1 = Protein Pdha1/1.
Pdk1 = Pyruvate dehydrogenase kinase 1.
Pdk2 = Pyruvate dehydrogenase kinase 1.
Pepb1 = Phosphatidylethanolamine-binding protein 1.
Pgk1 = Phosphoglycerate kinase 1.
Prdx2 = Peroxiredoxin-2.
Prdx5 = Peroxiredoxin-5.
Pygb = Glycogen phosphorylase.
Rps3 = 40 S ribosomal protein S3.
Sdha = Succinate dehydrogenase (ubiquinone) flavoprotein subunit.
Sdhb = Succinate dehydrogenase (ubiquinone) iron-sulfur subunit.
Sdhc = Succinate dehydrogenase complex, subunit C, integral membrane protein.
Slc25a3 = Phosphate carrier protein.
Sod1 = Superoxide dismutase [Cu-Zn].
Sod2 = Superoxide dismutase [Cu-Zn].
Sucla2 = succinyl-CoA synthetase.
Suclg1 = Succinyl-CoA synthetase (ADP/GDP-forming) subunit α.
Tgm2 = transglutaminase 2.
Vdac1 = Voltage-dependent anion-selective channel protein 1.
Vdac2 = Voltage-dependent anion-selective channel protein 2.
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